HER2 heterogeneity as a biomarker in cancer
US-12540359-B2 · Feb 3, 2026 · US
This page is not indexed by search engines while we improve data quality.
Nitta Hiro patents
Nitta Hiro is listed as an inventor on 18 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Nitta Hiro |
| Total patents | 18 |
| First publication | Sep 8, 2015 |
| Latest publication | Feb 3, 2026 |
Notable patents
Publications ranked by popularity score, then publication date.
Method of identifying treatment responsive non-small cell lung cancer using anaplastic lymphoma kinase (alk) as a marker
US-2023184772-A1 · Jun 15, 2023 · US
Method of identifying treatment responsive non-small cell lung cancer using anaplastic lymphoma kinase (ALK) as a marker
US-11499974-B2 · Nov 15, 2022 · US
Her2 heterogeneity as a biomarker in cancer
US-2021071270-A1 · Mar 11, 2021 · US
Multiplex her2 and estrogen receptor co-staining assays for detecting tumor heterogeneity
US-2021011023-A1 · Jan 14, 2021 · US
Method of identifying treatment responsive non-small cell lung cancer using anaplastic lymphoma kinase (alk) as a marker
US-2020225237-A1 · Jul 16, 2020 · US
Method of identifying treatment responsive non-small cell lung cancer using anaplastic lymphoma kinase (ALK) as a marker
US-10620207-B2 · Apr 14, 2020 · US
Multiplex assay for improved scoring of tumor tissues stained for pd-l1
US-2018031567-A1 · Feb 1, 2018 · US
MULTIPLEX TP53/CEN17/B CELL GENE-PROTEIN CO-DETECTION ASSAY AND UNIQUELY SPECIFIC PROBES FOR 19q12, INSR, ATM, DLEU2, TP53, AND 13q12
US-2017212122-A1 · Jul 27, 2017 · US
Method of identifying treatment responsive non-small cell lung cancer using anaplastic lymphoma kinase (alk) as a marker
US-2017205416-A1 · Jul 20, 2017 · US
Recent patents
Latest publications not already listed above.
Method of identifying treatment responsive non-small cell lung cancer using anaplastic lymphoma kinase (ALK) as a marker
US-9651555-B2 · May 16, 2017 · US
Significance of intratumoral her2 heterogeniety in breast cancer and uses therefore
US-2017082627-A1 · Mar 23, 2017 · US
Method of analyzing chromosomal inversions
US-9562259-B2 · Feb 7, 2017 · US
Multiplex her2 and estrogen receptor co-staining assays for detecting tumor heterogeneity
US-2017023579-A1 · Jan 26, 2017 · US
Simultaneous detection of mutational status and gene copy number
US-2016130666-A1 · May 12, 2016 · US
Multiplex assay for improved scoring of tumor tissues stained for pd-l1
US-2015346210-A1 · Dec 3, 2015 · US
Method of Identifying Treatment Responsive Non-Small Cell Lung Cancer Using Anaplastic Lymphoma Kinase (ALK) as a Marker
US-2015346206-A1 · Dec 3, 2015 · US
Substrates for chromogenic detection and methods of use in detection assays and kits
US-9127028-B2 · Sep 8, 2015 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Ventana Med Syst Inc | 18 |
| Nitta Hiro | 2 |
| Genentech Inc | 2 |
| Nat Cancer Ct | 2 |
| Kelly Brian Daniel | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| G01N33/5752 | 9 |
| G01N33/57423 | 8 |
| G01N2800/52 | 8 |
| A61K31/4545 | 7 |
| G01N2333/912 | 7 |